|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1999-1-28
|
|
pubmed:abstractText |
This study was performed to assess the acute effects of the new angiotensin II antagonist, candesartan cilexetil, on systemic and renal haemodynamics in patients with sustained essential hypertension [diastolic blood pressure (DBP) 95-114 mmHg].
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0031-6970
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
497-501
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:9832289-Acute-Phase Reaction,
pubmed-meshheading:9832289-Angiotensin II,
pubmed-meshheading:9832289-Angiotensin Receptor Antagonists,
pubmed-meshheading:9832289-Antihypertensive Agents,
pubmed-meshheading:9832289-Benzimidazoles,
pubmed-meshheading:9832289-Biphenyl Compounds,
pubmed-meshheading:9832289-Blood Pressure,
pubmed-meshheading:9832289-Female,
pubmed-meshheading:9832289-Hemodynamics,
pubmed-meshheading:9832289-Humans,
pubmed-meshheading:9832289-Hypertension,
pubmed-meshheading:9832289-Kidney,
pubmed-meshheading:9832289-Male,
pubmed-meshheading:9832289-Middle Aged,
pubmed-meshheading:9832289-Prodrugs,
pubmed-meshheading:9832289-Renal Circulation,
pubmed-meshheading:9832289-Renin,
pubmed-meshheading:9832289-Tetrazoles,
pubmed-meshheading:9832289-Vasodilation
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Acute effects of candesartan cilexetil (the new angiotensin II antagonist) on systemic and renal haemodynamics in hypertensive patients.
|
|
pubmed:affiliation |
Department of Clinical Physiology, Sahlgrenska University Hospital, Gothenborg, Sweden. katarina.fridman@hassle.se.astra.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
